Delayed diagnosis of pyoderma gangrenosum: A case study

Ostomy Wound Management

Volumn 54, Issue 11, 2008, Pages 32-36

  Contreras Ruiz, Jose ^a,b   Kresch Tronik, Nicole S ^b   De La Cruz Garcia, Maria Isabel ^b   Mercado Ceja, Sergio ^a   Lozano Platonoff, Adriana ^a  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b IWOCC ^*  (Mexico)

Author keywords

Case study; Diagnosis; Pyoderma gangrenosum; Skin ulcer

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANAMNESIS; ARTICLE; BANDAGE; BIOPSY; CASE REPORT; COMPRESSION GARMENT; DIAGNOSTIC ERROR; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PYODERMA GANGRENOSUM; RARE DISEASE; SKIN CARE; TIME; VARICOSIS; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; BANDAGES; BIOPSY; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDICAL HISTORY TAKING; MIDDLE AGED; PYODERMA GANGRENOSUM; RARE DISEASES; SKIN CARE; STOCKINGS, COMPRESSION; TACROLIMUS; TIME FACTORS; VARICOSE ULCER; WOUND HEALING;

EID: 59749101020     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Moschella SL. Neutrophillic dermatoses. In: Bolognia JL, Jorizzo JL, Rappini RP (eds). Dermatology, 1st ed. Madrid, Spain: Mosby;2003:411-424.
2. Wollina U. Pyoderma gangrenosum - a review. Orphanet J Rare Dis. 2007;2:19.
3. Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS. Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol. 2004;140(7):861-864.
4. Clark HH, Cohen PR. Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol. 1995;32(5 Pt 2):912-914.
5. Hidano A, Watanabe K. Pyoderma gangrenosum and cardio-vasculopathies, particularly Takayasu arteritis. Review of the Japanese literature (author's transl). Ann Dermatol Venereol. 1981;108(1):13-21.
6. Ho KK, Otridge BW, Vandenberg E, Powell FC. Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol. 1992;27(5 Pt 2):804-808.
7. Olson K. Pyoderma gangrenosum with systemic LE. Acta Derm Venereol. 1971;51(3):233-234.
8. Paller AS, Sahn EE, Garen PD, Dobson RL, Chadwick EG. Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome. J Pediatr. 1990;117(1 Pt 1):63-66.
9. Stingl G, Hintner H, Wolff K. Pyoderma gangrenosum. Hautarzt. 1981;32(4):165-172.
10. van der Sluis I. Pyoderma (ecthyma) gangrenosum in 2 patients with a beta-2A paraprotein in their blood. Ned Tijdschr Geneeskd. 1965;109(31):1427- 1433.
11. van der Sluis I. Two cases of pyoderma (ecthyma) gangrenosum associated with the presence of an abnormal serumprotein (beta-2-A-paraprotein). With a review of the literature. Dermatologica. 1966;132(5):409-424.
12. Wolff K, Stingl G. Pyoderma gangrenosum. In: Freedberg I, Eisen A, Wolff K. et al (eds). Fitpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill;1999:1140-1148.
13. Freiman A, Brassard A. Pyoderma gangrenosum associated with isotretinoin therapy. J Am Acad Dermatol. 2006;55(5 suppl):S107-S108.
14. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33(4):787-802,vi.
15. Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347 (18):1412-1418.
16. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ. 2006;333(7560):181-184.
17. Koo K, Brem H, Lebwohl M. Pyoderma gangrenosum versus chronic venous ulceration: comparison of diagnostic features. J Cutan Med Surg. 2007;10(1):26-30.
18. Zhang XB, He YQ, Zhou H, Luo Q, Li CX. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin Med J (Engl). 2006;119(14):1230-1232.
19. Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangrenosum using etanercept. J Am Acad Dermatol. 2006;54(3 suppl 2):S128-S134.
20. De la Morena F, Martin L, Gisbert JP, Fernandez HJ, Goiriz R. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab. Inflamm Bowel Dis. 2007;13(4):509-510.
21. Nousari HC, Lynch W, Anhalt GJ, Petri M. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol. 1998;134(12):1509-1511.